Green Thumb Industries (GTBIF) Long-Term Investments (2018 - 2026)
Green Thumb Industries (GTBIF) posted Long-Term Investments of $32.7 million for Q1 2026, little changed on a QoQ basis from $32.7 million in Q4 2025, and down 24.84% year-over-year from $43.5 million in Q1 2025.
Green Thumb Industries (GTBIF) Long-Term Investments (2018 - 2026) Analysis & Trends
Green Thumb Industries' Long-Term Investments history runs 9 years deep, the most recent figure standing at $32.7 million for Q1 2026.
- Quarterly Long-Term Investments fell 24.84% year-over-year to $32.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.7 million (down 24.84% YoY) and the FY2025 annual result came in at $32.7 million, down 24.92% from the prior year.
- Long-Term Investments was $32.7 million for Q1 2026 at Green Thumb Industries, roughly flat from $32.7 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $90.7 million in Q1 2022 and bottomed at $32.7 million in Q1 2026.
- A 5-year average of $61.3 million and a median of $61.4 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments surged 212.16% — and 2024, when it tumbled 32.29%.
- Green Thumb Industries' Long-Term Investments stood at $74.2 million in 2022, then retreated by 13.22% to $64.4 million in 2023, then tumbled by 32.29% to $43.6 million in 2024, then dropped by 24.92% to $32.7 million in 2025, then decreased by 0.17% to $32.7 million in 2026.
- Business Quant data shows GTBIF's Long-Term Investments at $32.7 million in Q1 2026, $32.7 million in Q4 2025, and $43.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 32.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.66 Mn |
| Dec 31, 2025 | 32.72 Mn |
| Sep 30, 2025 | 43.74 Mn |
| Jun 30, 2025 | 43.84 Mn |
| Mar 31, 2025 | 43.46 Mn |
| Dec 31, 2024 | 43.58 Mn |
| Sep 30, 2024 | 61.42 Mn |
| Jun 30, 2024 | 61.41 Mn |
| Mar 31, 2024 | 60.85 Mn |
| Dec 31, 2023 | 64.36 Mn |
| Sep 30, 2023 | 77.34 Mn |
| Jun 30, 2023 | 75.06 Mn |
| Mar 31, 2023 | 75.67 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 79.98 Mn |
| Jun 30, 2022 | 81.78 Mn |
| Mar 31, 2022 | 90.73 Mn |
| Dec 31, 2021 | 94.90 Mn |
| Sep 30, 2021 | 50.63 Mn |
| Jun 30, 2021 | 41.73 Mn |